�ֲ���ý

Clair Huffine is a 2025 PhD candidate in the Cameron Laboratory. She recently won the 2023 Biophysics Supergroup Outstanding Research Presentation Award; is a 2023 P.E.O. SCHOLARS Award applicant; and in 2022 was an NIH/CU Molecular

Damon Runyon Cancer Research Foundation awards $3.9 million to exceptional early-career scientistsNicole Marie Hoitsma, PhD [HHMI Fellow], with her sponsor Karolin Luger, PhD, at University of Colorado, �ֲ���ý, has been named one of 13 new Damon

Emily Kibby is a 2025 PhD candidate in Biochemistry in the Aaron Whiteley Research Group. She became an NIH Signaling and Cellular Regulation Trainee in 2020 and in 2021 received a Graduate Teaching Award.A BLOOMING SCIENTIST It

Calvin Voong is a 2024 PhD Candidate in Biochemistry, Biophysics, and Molecular Biology in the Goodrich-Kugel Research Group. In 2019 he received a Graduate Teaching Award; in 2021 he received a Department Service Award; and in 2023 was a member of

Sometimes life tells us we’re meant to do something. In Camila Sousa’s case, it started young, growing up in a house in �ֲ���ý with not one but two PhD scientists for parents. Camila’s mom is a molecular biologist, and her dad

Dr. Stephanie Moon is working on ridding the world of disease. Beginning with an early obsession with finding a cure for chicken pox, Dr. Moon set her sights on RNA viruses, a family which includes some of the most prolific

Though she sounds every bit the polished Silicon Valley CEO while discussing spin-ups, revenue streams, and funding runways, Dr. Tina Boville first describes herself as “a huge nerd.” via Zoom. A CU Biochem doctoral alum, Tina grew up on Anne

Dr. Celso Espinoza is a senior drug discovery investigator with the biopharmaceutical firm AbbVie. Originally a component of Abbott Laboratories, AbbVie split in 2013 to focus on new drug discovery, and Celso followed.

Graycen Wheeler is a 6th year graduate student in BCHM's Liu Lab. She was initially attracted to CU Biochem by the strong web presence and diversity of research in the department’s labs. During graduate recruitment, “the

Otto Kletzien likes to stay busy. He’s a Signaling and Cellular Regulation (SCR) fellow, one of approximately 15 in the department, an active participant and former leader of CU �ֲ���ý’s RNA Club chapter, for which he ran